Top compounds associated with response to MRPL39


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.001
mRNA paclitaxel CCLE pan-cancer AAC 0.15 0.001
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.001
mRNA linifanib GDSC1000 pan-cancer AAC -0.12 0.001
mRNA XL-184 GDSC1000 pan-cancer AAC -0.11 0.001
mRNA PD318088 CTRPv2 pan-cancer AAC -0.11 0.002
mRNA SN-38 CTRPv2 pan-cancer AAC 0.12 0.002
mRNA Vinblastine GDSC1000 pan-cancer AAC 0.11 0.002
mRNA LE-135 CTRPv2 pan-cancer AAC 0.12 0.002
mRNA JQ-1 CTRPv2 pan-cancer AAC -0.1 0.002
Download CSV